Roche announces the retirement of James Sabry, Head of Roche Pharma Partnerships, and the appointment of Boris Zaïtra, currently Head of Business Development, as Head of Corporate Business Development, effective July 1.

In this new role, which will combine the pharma partnering and business development functions, Boris Zaïtra will become a member of the company's extended management, reporting to CEO Thomas Schinecker, and will remain based in Basel.

Boris Zaïtra joined the Swiss healthcare group in 2012 in his current role. Prior to this, he gradually expanded his management responsibilities in mergers and acquisitions across multiple sectors.

Copyright (c) 2024 CercleFinance.com. All rights reserved.